Third Arc Bio
Recent Finacing
Series A ext
Recent Raise
$52M
Third Arc Bio is a clinical-stage biotech developing multifunctional antibodies that precisely modulate T-cell activity for oncology and immunology & inflammation diseases.
Recent Finacing
Recent Raise
Third Arc Bio is a clinical-stage biotech developing multifunctional antibodies that precisely modulate T-cell activity for oncology and immunology & inflammation diseases.
